ADALTA LIMITED - Announcements

0.00%

0.4¢

Market Cap $11.90M

Healthcare Biotechnology

AdAlta Limited is an Australia-based drug discovery and development company. The Company... AdAlta Limited is an Australia-based drug discovery and development company. The Company is focused on using its technology platform to generate protein therapeutics, known as i-bodies, for treating a range of human diseases. The Company's principal activity is to develop its ibody platform with a focus on its lead candidate AD-114, a treatment for idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases. Its i-body AD-114 drug candidate is used for treatment in various fibrosis related eye diseases to support the pre-clinical development of the eye fibrosis indication. The Company's AD-114 has shown both anti-fibrotic and anti-inflammatory effects in various animal models. The Company's AD-114 is used in various therapeutic applications for fibrosis diseases of the liver, skin, kidney and heart. AD-114 has completed pre-clinical studies in vitro (in the lab) and in vivo (in animals) data obtained.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

1AD	AdAlta presenting at 3rd ANZ Biologics Festival		04/02/25	Share
1AD	Appendix 4C - Quarter Ended 31 March 2018	PRICE SENSITIVE	23/04/18	Share
1AD	Interview AdAlta CEO AD-214		18/04/18	Share
1AD	Shareholder information sessions		18/04/18	Share
1AD	Investor presentation		18/04/18	Share
1AD	AdAlta to advance improved lung fibrosis therapy, AD-214	PRICE SENSITIVE	18/04/18	Share
1AD	Appendix 3B		26/02/18	Share
1AD	Investor Presentation		02/02/18	Share

1AD AdAlta presenting at 3rd ANZ Biologics Festival
04/02/25		Share
1AD Appendix 4C - Quarter Ended 31 March 2018
23/04/18	PRICE SENSITIVE	Share
1AD Interview AdAlta CEO AD-214
18/04/18		Share
1AD Shareholder information sessions
18/04/18		Share
1AD Investor presentation
18/04/18		Share
1AD AdAlta to advance improved lung fibrosis therapy, AD-214
18/04/18	PRICE SENSITIVE	Share
1AD Appendix 3B
26/02/18		Share
1AD Investor Presentation
02/02/18		Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 0.4¢		Change 0.000(0.00%)		Mkt cap ! $11.90M

Open	High	Low	Volume
0.4¢	0.4¢	0.4¢	401.9K

Buyers (Bids)

Vol.	Price($)
26763664	0.3¢

Sellers (Offers)

Price($)	Vol.
0.4¢	11209721

Last trade - 10.23am 29/07/2026 (20 minute delay)

1AD (ASX) Chart